Comparison between Rayzon Solar IPO and Sudeep Pharma IPO.
Rayzon Solar IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Sudeep Pharma IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Rayzon Solar IPO is up to ₹1,500.00 Cr whereas the issue size of the Sudeep Pharma IPO is up to ₹895.00 Cr. The final issue price of Rayzon Solar IPO is and of Sudeep Pharma IPO is ₹593.00 per share.
| Rayzon Solar IPO | Sudeep Pharma IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹1 per share |
| Issue Price (Lower) | ₹563.00 per share | |
| Issue Price (Upper) | ₹593.00 per share | |
| Issue Price (Final) | ₹593.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 25 shares | |
| Fresh Issue Size | 0 shares | 16,02,023 shares |
| Fresh Issue Size (Amount) | up to ₹1,500.00 Cr | up to ₹95.00 Cr |
| OFS Issue Size | 0 shares | 1,34,90,726 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹800.00 Cr |
| Issue Size Total | 0 shares | 1,50,92,749 shares |
| Issue Size Total (Amount) | up to ₹1,500.00 Cr | up to ₹895.00 Cr |
Rayzon Solar IPO opens on , while Sudeep Pharma IPO opens on Nov 21, 2025. The closing date of Rayzon Solar IPO and Sudeep Pharma IPO is , and Nov 25, 2025, respectively.
| Rayzon Solar IPO | Sudeep Pharma IPO | |
|---|---|---|
| Anchor Bid Date | Nov 20, 2025 | |
| Issue Open | Nov 21, 2025 | |
| Issue Close | Nov 25, 2025 | |
| Basis Of Allotment (Tentative) | Nov 26, 2025 | |
| Initiation of Refunds (Tentative) | Nov 27, 2025 | |
| Credit of Share (Tentative) | Nov 27, 2025 | |
| Listing date (Tentative) | Nov 28, 2025 | |
| Anchor Lockin End date 1 | Dec 26, 2025 | |
| Anchor Lockin End date 2 | Feb 24, 2026 |
Rayzon Solar IPO P/E ratio is , as compared to Sudeep Pharma IPO P/E ratio of 47.61.
| Rayzon Solar IPO | Sudeep Pharma IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)Sudeep Pharma Ltd.'s revenue increased by 10% and profit after tax (PAT) rose by 4% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 98.1 | 89.37 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 76.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 47.61 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹6697.85 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹12.46 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 27.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Rayzon Solar IPO Retail Individual Investors (RII) are offered while in Sudeep Pharma IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Rayzon Solar IPO and 30,18,550 shares in Sudeep Pharma IPO.
| Rayzon Solar IPO | Sudeep Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | 45,27,823 shares | |
| Market Maker Reservation | 0 shares | |
| QIB | 30,18,550 shares | |
| NII | 22,63,913 shares | |
| RII | 52,82,463 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 1,50,92,749 shares |
Rayzon Solar IPO subscribed in total, whereas Sudeep Pharma IPO subscribed 93.71x.
| Rayzon Solar IPO | Sudeep Pharma IPO | |
|---|---|---|
| QIB (times) | 213.08x | |
| NII (times) | 116.72x | |
| Big NII (times) | 134.91x | |
| Small NII (times) | 80.33x | |
| RII (times) | 15.65x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 93.71x |
